On ECHEMI
Home > Drugs > Thioridazine Hydrochloride Tablets

Thioridazine Hydrochloride Tablets

Function and Efficacy

This product is a phenothiazine antipsychotic. Its antipsychotic effect is mainly due to blocking dopamine receptors in the brain. It has a weak effect on dopamine receptors in the extrapyramidal system and the body temperature center, and its sedative effect is also weak.

Ingredients

The main ingredient of this product is: Thioridazine hydrochloride. Its chemical name is: 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-methylthiophenothiazine hydrochloride.

Name Description Content CAS NO. Manufacturer
Thioridazine hydrochlorideIngredients

This product is a phenothiazine antipsychotic. Its antipsychotic effect is mainly due to blocking dopamine receptors in the brain. It has a weak effect on dopamine receptors in the extrapyramidal system and the body temperature center, and its sedative effect is also weak.

More
130-61-0 11

Appearance

This product is a sugar-coated tablet. After removing the sugar coating, it appears white or off-white.

Indication

Acute and chronic schizophrenia and ADHD in children.

Usage and Dosage

Oral. The initial dose is 25 mg once, 3 times a day. Increase by 25 mg every 2 to 3 days, gradually increasing to the optimal dose. 1 mg/kg per day for children aged 1 to 5 years, 5 to 15 mg per day for children over 5 years old, divided into two doses.

Adverse Reactions

Common adverse reactions include dry mouth, tachycardia, blurred vision, etc. Drowsiness, dizziness, nasal congestion, postural hypotension, diarrhea, abdominal distension, abnormal electrocardiogram, toxic liver damage, long-term use can cause pigmentary retinopathy, most of which disappear after stopping the drug. It rarely causes extrapyramidal adverse reactions such as tremor, drooling, bradykinesia, akathisia and acute dystonia.

Precautions

1. Patients with severe cardiovascular diseases such as heart failure, myocardial infarction, conduction abnormalities, etc. are prohibited from using this product. 2. Patients with coma or leukopenia are prohibited from using this product. 3. Patients who are allergic to phenothiazines and this product are prohibited from using this product.

Drug Interactions

1. This product can enhance the central inhibitory effect of analgesics, hypnotics, antihistamines, anesthetics and ethanol. 2. It should not be used in combination with quinidine.

Storage

Keep away from light and store in sealed container.

Packaging Specification

50mg

Manufacturer

Hunan Dongting Pharmaceutical Co., Ltd.

  • Founded in:

    1997-03-26
  • Address:

    No. 16 Dongyan Road, Chenjiagang Community, Deshan Subdistrict Office, Changde Economic and Technological Development Zone, Hunan Province (No. 16 Dongyan Road, Deshan District, Changde City)
  • Tax NO.:

    914307001838043692
  • Registered Funds:

    309.624852 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.